furosemide has been researched along with Hypokalemic Periodic Paralysis in 3 studies
Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
Hypokalemic Periodic Paralysis: An autosomal dominant familial disorder characterized by recurrent episodes of skeletal muscle weakness associated with falls in serum potassium levels. The condition usually presents in the first or second decade of life with attacks of trunk and leg paresis during sleep or shortly after awakening. Symptoms may persist for hours to days and generally are precipitated by exercise or a meal high in carbohydrates. (Adams et al., Principles of Neurology, 6th ed, p1483)
| Excerpt | Relevance | Reference |
|---|---|---|
| "We conclude that is a case of pseudo-Bartter's syndrome that was caused by long-term ingestion of the health tea supplemented illegally with furosemide, and suspect that such cases may be observed more frequently than currently thought." | 1.32 | [A case of pseudo-Bartter's syndrome induced by long-term ingestion of furosemide delivered orally through health tea]. ( Abe, M; Arakawa, M; Ieiri, T; Ishimitsu, T; Kono, K; Matsuoka, H; Numabe, A; Ogata, A; Takahashi, M; Yagi, S, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lybecker, MB | 1 |
| Madsen, HB | 1 |
| Bruun, JM | 1 |
| Wu, F | 1 |
| Mi, W | 1 |
| Cannon, SC | 1 |
| Numabe, A | 1 |
| Ogata, A | 1 |
| Abe, M | 1 |
| Takahashi, M | 1 |
| Kono, K | 1 |
| Arakawa, M | 1 |
| Ishimitsu, T | 1 |
| Ieiri, T | 1 |
| Matsuoka, H | 1 |
| Yagi, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomised, Double-blind, Placebo-controlled, Phase II Clinical Trial With a Cross-over Design Assessing Efficacy of a Single Dose of Bumetanide in Reducing Focal Attack Severity in Hypokalaemic Periodic Paralysis Assessed Using the McManis Protocol[NCT02582476] | Phase 2 | 12 participants (Anticipated) | Interventional | 2015-01-31 | Terminated (stopped due to Slow enrolment and end of funding) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 other studies available for furosemide and Hypokalemic Periodic Paralysis
| Article | Year |
|---|---|
Severe hypokalaemia as a cause of acute transient quadriparesis.
Topics: Administration, Intravenous; Arrhythmias, Cardiac; Diuretics; Furosemide; Humans; Hypokalemic Period | 2017 |
Beneficial effects of bumetanide in a CaV1.1-R528H mouse model of hypokalaemic periodic paralysis.
Topics: Acetazolamide; Animals; Arginine; Bumetanide; Calcium Channels, L-Type; Carbonic Anhydrase Inhibitor | 2013 |
[A case of pseudo-Bartter's syndrome induced by long-term ingestion of furosemide delivered orally through health tea].
Topics: Adult; Bartter Syndrome; Biomarkers; Diagnosis, Differential; Diuretics; Female; Food, Organic; Furo | 2003 |